Medical Devices Startups

Vega BioImaging develops a cancer diagnostic platform combining nanobead technology, optical imaging, and AI-powered analysis to enable quantitative detection of multiple cancer biomarkers simultaneously in tissue biopsies. The solution improves upon traditional immunohistochemistry methods for pathology laboratories and clinical research settings.

1 investor

VeinCentre is a UK medical provider specialising in the diagnosis and treatment of varicose veins, venous leg ulcers, and facial thread veins using minimally invasive, walk-in walk-out procedures. Operating over 40 clinics nationwide, it serves patients seeking vein care and is the country's largest dedicated vein specialist.

1 investor

Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.

1 investor

Venous Stent develops ALTA®, a modular stent designed to treat deep venous disease in the iliac and femoral veins. The company combines clinical expertise with engineering to create anatomy-adaptive solutions for physicians treating complex venous conditions.

1 investor

Ventinova Medical develops and markets medical devices for airway management and patient ventilation, including the Evone mechanical ventilator, Ventrain manual ventilator, Tritube ultrathin tube, and Cricath transtracheal catheter, all based on flow-controlled ventilation (FCV) with active expiration. Its products are aimed at clinicians in anesthesiology and intensive care.

1 investor

Ventora Medical develops a neonatal airway pressure monitoring device for clinicians managing non-invasive respiratory support in newborn patients. The device provides continuous, accurate measurement of airway pressure delivered by CPAP and high-flow nasal cannula systems.

1 investor

VentriJect develops Seismofit, a device that uses seismocardiography to measure VO2max as an indicator of cardiovascular fitness. Founded as a spin-out from Aalborg University's cardiology research center, the company operates in the medical device sector.

1 investor

VentriPace Medical develops cardiac rhythm management technology using sensing and remote monitoring to support short-term management of transient conduction disturbances following procedures such as TAVI and cardiac surgery. The medtech company serves clinicians and cardiac patients, aiming to reduce unnecessary permanent pacemaker implants and hospital stays.

1 investor

Ventuno is a biotech company developing cancer therapies that leverage the immune system to target and eliminate cancer cells in difficult-to-treat tumors. The company focuses on immunotherapy approaches to advance cancer care.

1 investor

Vera Health develops AI-powered clinical decision support software for emergency medicine departments and physicians. The company serves healthcare providers seeking to improve patient outcomes and operational efficiency in emergency settings.

1 investor

VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.

1 investor

Veranex is a contract research organization (CRO) for the medical device and diagnostics industry, combining product design, engineering, manufacturing, preclinical, clinical, regulatory, quality, and market-access services under one roof. It supports medtech companies from early concept through commercialization to bring devices and diagnostics to market.

1 investor

Verax Biomedical develops rapid bacterial contamination detection tests for blood products and tissues intended for transfusion and transplantation. The company serves blood banks, hospitals, and transfusion centers seeking to prevent infectious complications from bacterial growth in stored cellular materials.

1 investor

VERDOT designs and manufactures downstream purification solutions for biopharmaceutical and biotechnology companies to enable the production of therapeutic biologics. The company has over 70 years of manufacturing experience, with more than three decades focused on bioprocessing.

1 investor

Verge Medical (formerly Ostial Corporation) develops medical devices for aorto-ostial vascular interventions, including the FLASH Flex aorto-ostial angioplasty system and the RoVo mechanical thrombectomy device, used by physicians for coronary and peripheral vascular cases. The devices are sold to hospitals and office-based settings, primarily in the United States.

1 investor

Vernal Biosciences is an mRNA contract development and manufacturing organization (CDMO) that produces high-quality mRNA for research and therapeutic development. The company serves researchers and biotech companies seeking reliable mRNA supply for drug discovery and clinical applications.

1 investor

Verogen provides NGS sequencing systems and reagent solutions for forensic and research laboratories, with offerings including the MiSeq FGx Sequencing System and flexible financing options like leasing, reagent rental programs, and bundled workflows.

1 investor

Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma. Its products serve dermatology prescribers, payers, and patients, with a lead drug-device combination based on topical cantharidin.

1 investor

Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients. The company uses a patient-based discovery engine to identify novel targets for immunotherapy, focusing on treating solid tumors where macrophages are prevalent.

1 investor

Versono Medical develops endovascular medical device technology for interventional cardiology and vascular surgery applications. The company is based in Ireland and the USA with backing from experienced medical device executives and clinicians.

1 investor

Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure. It targets patients with uncontrolled hypertension who do not respond well to medication.

1 investor

Veryan Medical develops the BioMimics 3D Vascular Stent System, a three-dimensional nitinol stent designed around swirling blood flow mechanics to treat vascular disease. Spun out from Imperial College London, the company serves physicians treating peripheral vascular conditions.

1 investor

Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke. The company serves hospitals and neurosurgeons seeking advanced treatment options.

1 investor

Vespper builds a document infrastructure platform for regulated industries, with initial focus on pharmaceutical and clinical workflows. The platform serves regulated organizations handling sensitive documents in highly compliance-driven environments.

1 investor